107 results for funding information
Refine Your Search
National Cancer Institute's Cancer Information Service
To provide accurate, , and reliable information on cancer that is easy to understand; this free service is a federally funded cancer education program…
CDP Information & Policies
For information about other programs, click here. For information about applying for LLS research funding, click here. Grant Requirements Reporting Sc…
SCOR Information & Policies
For information about other programs, click here. For information about applying for LLS research funding, click here. Grant Requirements Reporting Sc…
TRP Information & Policies
For information about other programs, click here. For information about applying for LLS research funding, click here. Grant Requirements Reporting Sc…
RTFCCR/LLS Prevention Information & Policies
For information about other programs, click here. For information about applying for LLS research funding, click here. Grant Requirements Reporting Sc…
Blood & Marrow Transplant Information Network (BMT InfoNet)
BMT InfoNet is dedicated to providing transplant patients, survivors and their loved ones with emotional support and high quality, information about …
Defining and Redefining a Blood Cancer Diagnosis
Science historian June Goodfield wrote, “Cancer begins and ends with people.” This Blood Cancer Awareness Month, it’s important to know that The Leu…
Welcome to Blood Cancer United
Things look a little different around here. The Leukemia & Lymphoma Society (LLS) has a new name: Blood Cancer United. You may be asking a question we…
Blog
Balancing fiscal responsibility with saving and improving lives
Table of contents:Balancing Fiscal Responsibility with Saving and Improving LivesThe LLS Bold Goal: Accelerate Progress in Blood CancerLLS’s role in p…
Shop Online and In-Store at Walgreens to Support LLS
The Leukemia & Lymphoma Society (LLS) and Walgreens are in your corner. Since , Walgreens has helped to raise more than $ million for LLS and Susan G…
Another First: FDA Approves Car T-Immunotherapy for Treatment of Aggressive Form of Indolent Non-Hodgkin Lymphoma
The U.S. Food and Drug Administration (FDA) today approved the CAR treatment axicabtagene ciloleucel (Yescarta®) for patients with follicular lymphom…
Understanding Myeloma: A Quick Guide
Myeloma is a rare blood cancerLet’s address the elephant in the room. Myeloma is not a skin cancer—that’s melanoma. And it’s not a bone cancer—althoug…
CAR-T Immunotherapy Showing Positive Results
This week, positive data from a Kite Pharma immunotherapy clinical trial was released showing that more than of refractory aggressive lymphoma (NHL…
The Leukemia & Lymphoma Society's New Chief Scientific Officer Excited about What's Next in Blood Cancer Research
Lore Gruenbaum, Ph.D., was promoted to The Leukemia & Lymphoma Society’s (LLS) Chief Scientific Officer (CSO) following the retirement of longtime CSO…
A guide to Blood Cancer Awareness Month
Hope. When times are tough, it’s often hope people look for. We want things to work out, to see reasons to keep going. You hear “hope” a lot in conjun…
Blog
Count on LLS this Blood Cancer Awareness Month
September is Blood Cancer Awareness Month, and The Leukemia & Lymphoma Society is leading the way in blood cancer support, research, and advocacy.
FAQs: Proposed federal spending cuts and blood cancer research and care
The Leukemia & Lymphoma Society (LLS) has heard great concerns from patients, caregivers, volunteers, healthcare professionals, researchers, community…
News Release
Ushering In a New Era of Pediatric Blood Cancer Treatment and Care
We caught up with Gwen Nichols, MD, Chief Medical Officer at The Leukemia & Lymphoma Society (LLS), to share the progress we’re making to bring cures …
Holding onto hope: Living with chronic lymphocytic leukemia
Table of contents:Living with CLL: symptoms, treatment, & supportWhat is CLLCLL stagesCLL symptomsCLL testing and diagnosisCLL treatmentPrognosi…
_dam_file_163661.jpg?crop=true&keep=c&w=400&h=400)
Breaking Down Barriers in Blood Cancer Care
When I meet blood cancer survivors and their families, they often share their personal stories with me. Sometimes they talk about the relief of findin…
Understanding AML vs. ALL: Navigating the complex field
Table of contents: Understanding AML vs. ALL: Navigating the complex fieldSimilarities and differences between AML and ALLCauses and risk factors: Und…
Finding Support in Community: Walgreens and LLS Show Up for Blood Cancer Patients
We all need a helping hand sometimes. Add on a cancer diagnosis and the everyday suddenly feels... different. In many ways, harder. Fear. Anger. Conf…
FDA Approves First CAR T-Immunotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia
The U.S. Food and Drug Administration (FDA) recently announced approval of brexucabtagene autoleucel (Tecartus®) as the first and only CAR treatment …
Why Monthly Giving Matters
Giving regularly over time = giving patients and survivors the chance for more time. Monthly giving really deserves more credit—credit as a predictab…
Predisposing factors to leukemia
Table of contents:Predisposing Factors to LeukemiaLeukemia CausesGenetic MutationsIs Leukemia Hereditary?Causes of Leukemia in AdultsCauses of Leukemi…